Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases and Pregnancy Complications

Explore clinical trials studying Female Urogenital Diseases and Pregnancy Complications. Study availability and eligibility vary by location and protocol.

27,030 public trials 4,555 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases and Pregnancy Complications trial results

Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

NCT06787612

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Health La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 56 locations
View Trial Details
Recruiting

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT05488340

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Enterobacteriaceae Infections, +9 more
Locations
  • Research Site 138 Fresno, California, United States
  • Research Site 131 Lancaster, California, United States
  • Research Site 123 Los Angeles, California, United States
  • Research Site 125 Montebello, California, United States
View all 17 locations
View Trial Details
Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (RCC), Carcinoma, +14 more
Locations
  • Local Institution - 0178 Palo Alto, California, United States
  • Local Institution - 0117 New Haven, Connecticut, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Local Institution - 0177 Miami, Florida, United States
View all 96 locations
View Trial Details

Related conditions